Abstract
Alzheimer’s disease (AD) is a clinically, anatomically and biologically heterogeneous disorder encompassing a wide spectrum of cognitive profiles, ranging from the typical amnestic syndrome to visuospatial changes in posterior cortical atrophy, language deficits in primary progressive aphasia and behavioural/executive dysfunctions in anterior variants. With the emergence of functional imaging and neural network analysis using graph theory for instance, some authors have hypothesized that this phenotypic variability is produced by the differential involvement of large-scale neural networks – a model called ‘molecular nexopathy’. At the moment, however, the hypothesized mechanisms underlying AD’s divergent network degeneration remain speculative and mostly involve selective premorbid network vulnerability. Herein we present an overview of AD’s clinicoanatomical variability, outline functional imaging and graph theory contributions to our understanding of the disease and discuss ongoing debates regarding the biological roots of its heterogeneity. We finally discuss the clinical promises of statistical signal processing disciplines (graph theory and information theory) in predicting the trajectory of AD variants. This paper aims to raise awareness about AD clinicoanatomical heterogeneity and outline how statistical signal processing methods could lead to a better understanding, diagnosis and treatment of AD variants in the future.
Keywords: Alzheimer’s disease, frontal AD, functional connectivity, heterogeneity, logopenic aphasia, posterior cortical atrophy, selective network vulnerability.
Current Alzheimer Research
Title:Untangling Alzheimer’s Disease Clinicoanatomical Heterogeneity Through Selective Network Vulnerability – An Effort to Understand a Complex Disease
Volume: 13 Issue: 5
Author(s): David Bergeron, Reda Bensaïdane and Robert Laforce
Affiliation:
Keywords: Alzheimer’s disease, frontal AD, functional connectivity, heterogeneity, logopenic aphasia, posterior cortical atrophy, selective network vulnerability.
Abstract: Alzheimer’s disease (AD) is a clinically, anatomically and biologically heterogeneous disorder encompassing a wide spectrum of cognitive profiles, ranging from the typical amnestic syndrome to visuospatial changes in posterior cortical atrophy, language deficits in primary progressive aphasia and behavioural/executive dysfunctions in anterior variants. With the emergence of functional imaging and neural network analysis using graph theory for instance, some authors have hypothesized that this phenotypic variability is produced by the differential involvement of large-scale neural networks – a model called ‘molecular nexopathy’. At the moment, however, the hypothesized mechanisms underlying AD’s divergent network degeneration remain speculative and mostly involve selective premorbid network vulnerability. Herein we present an overview of AD’s clinicoanatomical variability, outline functional imaging and graph theory contributions to our understanding of the disease and discuss ongoing debates regarding the biological roots of its heterogeneity. We finally discuss the clinical promises of statistical signal processing disciplines (graph theory and information theory) in predicting the trajectory of AD variants. This paper aims to raise awareness about AD clinicoanatomical heterogeneity and outline how statistical signal processing methods could lead to a better understanding, diagnosis and treatment of AD variants in the future.
Export Options
About this article
Cite this article as:
Bergeron David, Bensaïdane Reda and Laforce Robert, Untangling Alzheimer’s Disease Clinicoanatomical Heterogeneity Through Selective Network Vulnerability – An Effort to Understand a Complex Disease, Current Alzheimer Research 2016; 13 (5) . https://dx.doi.org/10.2174/1567205013666151116125155
DOI https://dx.doi.org/10.2174/1567205013666151116125155 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface: Scope of Current Alzheimer Research Debomoy
Current Alzheimer Research A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets Athanasios Koukopoulos' Psychiatry: The Primacy of Mania and the Limits of Antidepressants
Current Neuropharmacology Trajectories of Age-Related Cognitive Decline and Potential Associated Factors of Cognitive Function in Senior Citizens of Beijing
Current Alzheimer Research miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion
Current Neurovascular Research Heterologous Production of Death Ligands’ and Death Receptors’ Extracellular Domains: Structural Features and Efficient Systems
Protein & Peptide Letters Editorial (Thematic Issue: Effective and Promising Treatments for Neurological Disorders and Cancer)
Current Pharmaceutical Design Chemical Composition and Biological Effects of Essential Oils from Some Aromatic and Medicinal Plants
The Natural Products Journal Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
Current Alzheimer Research Bidirectional Nature of Cardiovascular and Kidney Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Molecular Hydrogen as a Neuroprotective Agent
Current Neuropharmacology Statins May Prevent Atherosclerotic Disease in OSA Patients without Co-Morbidities?
Current Vascular Pharmacology Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design The Future of Neuroregenerative Therapy for Parkinson’s Disease
Current Tissue Engineering (Discontinued) Coumarin Compounds in Medicinal Chemistry: Some Important Examples from the Last Years
Current Topics in Medicinal Chemistry Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer’s Disease – A Mini-Review
Current Alzheimer Research HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Current HIV Research The Cellular Protective Effects of Rosmarinic Acid: From Bench to Bedside
Current Neurovascular Research Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment
Current Pharmaceutical Design 5-Hydroxymethylfurfural (HMF) in Organic Synthesis: A Review of its Recent Applications Towards Fine Chemicals
Current Organic Synthesis